title: Re: Ikuno et al.: Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study (Ophthalmology 2015;122:1220-7).
authors.affiliation: Department of Ophthalmology, Vanderbilt University, Nashville, Tennessee.
authors.forename: Shriji
authors.initials: S
authors.lastname: Patel
authors.affiliation: Department of Ophthalmology, Vanderbilt University, Nashville, Tennessee. Electronic address: skim30@gmail.com.
authors.forename: Stephen Jae
authors.initials: SJ
authors.lastname: Kim
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D047728:Myopia, Degenerative / Q000188:drug therapy*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; D040262:Receptors, Vascular Endothelial Growth Factor